U.S. Physical Therapy, Inc. - Q1 2007 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2007. U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics. As of the reporting date, the company operated 293 clinics across 41 states, having opened three new clinics and closed two during the quarter. The company primarily operates through subsidiary clinic partnerships where it holds a majority interest, alongside wholly-owned facilities.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Net Revenues | $34.62 million | $33.50 million |
| Net Income | $1.83 million | $1.48 million |
| Diluted EPS | $0.16 | $0.12 |
| Operating Cash Flow | $5.40 million | $5.13 million |
| Cash & Equivalents | $13.09 million | $10.95 million (Dec 31, 2006) |
| Total Debt (Notes Payable) | $1.19 million | $1.36 million |
| Operating Margin | 12.4% | 12.4% |
Note: Financial figures are in thousands unless otherwise noted. Operating margin calculated as Operating Income from Continuing Operations divided by Net Revenues.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 3.3% year-over-year, driven by a 6.0% increase in total patient visits (359,032 vs. 338,669). This volume growth was partially offset by a decrease in net patient revenue per visit from $97.17 to $95.47.
- Medicare Impact: The decrease in revenue per visit was primarily attributed to a 6.0% cut in Medicare reimbursement rates effective January 1, 2007. Medicare represented 19% of charges in Q1 2007.
- Cost Management: Clinic operating costs as a percentage of net revenues increased slightly to 75.0% from 74.1%. Salaries and related costs remained stable at 52.0% of net revenues.
- Discontinued Operations: The company reported a loss of $15,000 from discontinued operations (closed clinics) in Q1 2007, compared to a loss of $222,000 in Q1 2006.
- Reclassifications: Prior period financial statements were reclassified to conform with current presentation, specifically regarding minority interests in subsidiary limited partnerships and the classification of auction rate securities.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes cash equivalents and marketable securities ($14.6 million total) are sufficient to fund operations and development through at least March 2008. The company has a $5.0 million unsecured credit facility with no outstanding balance as of the filing date.
- Expansion Strategy: The company intends to continue developing new clinics and opening satellite locations. New clinics typically incur initial operating losses before becoming profitable.
- Regulatory Risks: Significant risks include changes in Medicare reimbursement rates, the complexity of the Medicare Cap (adjusted limit of $1,780 for 2007), and potential regulatory actions regarding compliance with federal and state laws.
- Acquisitions: The company continues to evaluate acquisition opportunities and the purchase of minority interests in existing partnerships. Recent acquisitions included contingent consideration clauses based on future operating results.
Investor Verification Checklist
- Medicare Reimbursement Sensitivity: Verify the impact of the 6.0% Medicare rate cut on future margins, given Medicare comprises 19% of charges.
- Visit Volume Trends: Confirm if the 6.0% increase in patient visits is sustainable, particularly noting the slight decline in "Mature Clinics" (excluding new openings).
- Discontinued Operations: Review the remaining lease obligations ($601,000) for the 31 clinics closed in 2006 to assess future cash outflows.
- Minority Interest Purchases: Monitor the company's strategy for buying out minority partners in clinic partnerships, which impacts cash flow and goodwill.
- Receivables Quality: Assess the allowance for doubtful accounts, which increased to 7.1% of total patient accounts receivable.